NCT06452719View on ClinicalTrials.gov

Letrozole and Misoprostol for Early Pregnancy Loss Management

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 22, 2024

Primary Completion Date

July 15, 2026

Study Completion Date

July 15, 2026

Conditions
Early Pregnancy LossMiscarriage in First TrimesterMiscarriage
Interventions
DRUG

Letrozole

Letrozole 10 mg orally daily for three consecutive days

DRUG

Misoprostol

Misoprostol 800 mcg vaginally within 24 hours of final letrozole dose

Trial Locations (1)

19104

RECRUITING

PEACE / Penn Medicine, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER